Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Chronic Lymphocytic Leukemia Chromosome 17 deletion Chronic Disease Del(17P) Disease Attributes Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Leukemia Leukemia, B-Cell Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Dokuz Eylum Medical Favulty

Izmir, Turkey (Türkiye)

Location status: Recruiting

Location contact

Fatih Demirkan, Prof

CONTACT

About this study

The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients diagnosed as CLL
18 years or older
Able and willing to provide the written informed consent

Exclusion criteria

Younger than 18 years

Treatment and study plan

Primary outcomes

First line therapy therapy protocol distrubition

Time frame: 36 months

The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting

Study contacts

Contact information is provided by the study sponsor or research team.

Fatih Demirkan, Prof

CONTACT

[email protected]

+90 542 515 17 80

Sponsors and collaborators

Lead sponsor

Fatih Demirkan, MD

Other

Registry information

Official study title

Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study

Acronym: CLLTRegistry

Important dates

Study start: 2017
Primary completion: 2023
Study completion: 2026
First posted: Jun 23, 2017
Registry last updated: Mar 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed